Zdrowie i gospodarka · 27/04/2016

FDA Requests Public Comment on Proposed Collection of Information for Clinical Laboratory Improvement Amendments Categorization

The Food and Drug Administration (FDA) is seeking public input on a proposed rule that would allow for the categorization of in vitro diagnostic tests under the Clinical Laboratory Improvement Amendments of 1998 (CLIA), without requiring a premarket review.